◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0474

Aceso Life Science Group Limited (0474) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Industrials · Rental & Leasing Services · DATA UPDATED 2026-08-10

Aceso Life Science Group Limited (0474) operates in the Rental & Leasing Services industry and is headquartered in Wan Chai, Hong Kong with about 41 employees. Its market capitalization is roughly HKD 1 billion. In the fiscal year ended 2025-03-31, 0474 reported HKD 195M in revenue and (HKD 895M) in net income.

Aceso Life Science Group Limited, an investment holding company, engages in the financial services, property leasing and development, and construction machinery businesses in Hong Kong and the United Kingdom.

Interactive charts & full statements →

0474 Revenue & Earnings History — Annual Income Statement

Income statement2025-03-312024-03-312023-03-312022-03-31
Total RevenueHKD 195MHKD 228MHKD 312MHKD 315M
Gross ProfitHKD 90MHKD 117MHKD 141MHKD 162M
Operating Income (EBIT)(HKD 24M)(HKD 34M)HKD 16MHKD 10M
Net Income(HKD 895M)(HKD 462M)(HKD 264M)(HKD 370M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0474 Free Cash Flow History

0474 Balance Sheet History

Balance sheet2025-03-312024-03-312023-03-312022-03-31
Total AssetsHKD 3.2BHKD 4.8BHKD 6.3BHKD 6.3B
Total LiabilitiesHKD 2.5BHKD 3.0BHKD 3.7BHKD 3.4B

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0474 viewer.

Other Companies in Rental & Leasing Services

← 0472All “0-9” companies0475 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.